Literature DB >> 21108665

Keloid histopathology after intralesional cryosurgery treatment.

Y Har-Shai1, I Mettanes, Y Zilberstein, O Genin, I Spector, M Pines.   

Abstract

BACKGROUND: Keloid presents a great healthcare challenge. The patients suffer from aesthetic disfiguration and occasionally from pruritus, pain and discomfort. Although various treatments are recommended, a single, highly effective treatment represents a great clinical need.
OBJECTIVE: The cellular events and histopathology that follow intralesional cryosurgery were evaluated including cell proliferation, the number of cells expressing fibroblast markers, collagen synthesis and organization and mast cell infiltration.
METHODS: Biopsies were collected before and after intralesional cryoneedle procedure. Collagen structure was evaluated with confocal microscopy. Mast cells, blood vessels and cell proliferation were evaluated using immunohistochemistry.
RESULTS: Keloids contain abnormally thick collagen bundles, organized in swirls comprising closely bound fibrils. After intralesional cryosurgery, the collagen bundles lost their swirl structure, the thickness of the collagen layer decreased, and the bundles became more compact with less space between the fibres. A clear distinct transition zone separated the treated from the unaffected area. The frozen tissue was devoid of proliferating cells and mast cells whereas the number of blood vessels remained unaltered. Most of the fibroblasts expressed all tested myofibroblast markers although some exclusively expressed one and not the other. Few nuclei were observed in the affected area after treatment and very few of them expressed any fibroblast markers.
CONCLUSIONS: Intralesional cryosurgery resulted in major changes in collagen structure and organization. The treatment reduced the number of proliferating cells, of myofibroblasts and of mast cells. These results may explain the reduction in no-response rate and the amelioration of the clinical symptoms after intralesional cryosurgery treatment. Journal of the European Academy of Dermatology and Venereology
© 2010 European Academy of Dermatology and Venereology. No claim to original US government works.

Entities:  

Mesh:

Year:  2010        PMID: 21108665     DOI: 10.1111/j.1468-3083.2010.03911.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

1.  Use of intralesional cryosurgery as an innovative therapy for keloid scars and a review of current treatments.

Authors:  Gary Goldenberg; Adam J Luber
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

Review 2.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 3.  Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Authors:  Jonathan P Andrews; Jaana Marttala; Edward Macarak; Joel Rosenbloom; Jouni Uitto
Journal:  Matrix Biol       Date:  2016-02-02       Impact factor: 11.583

4.  The outcome of postoperative radiation therapy following plastic surgical resection of recurrent ear keloid: a single institution experience.

Authors:  Reham Mohamed; Abosaleh Abosaleh Elawadi; Reham Al-Gendi; Safa Al-Mohsen; Shabeer Wani; Ahmed Wafa
Journal:  J Egypt Natl Canc Inst       Date:  2022-01-24

5.  Could -79 °C Spray-Type Cryotherapy Be an Effective Monotherapy for the Treatment of Keloid?

Authors:  Tae Hwan Park; Hyeon-Ju Cho; Jang Won Lee; Chan Woo Kim; Yosep Chong; Choong Hyun Chang; Kyung-Soon Park
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 6.  Lasers and ancillary treatments for scar management Part 2: Keloid, hypertrophic, pigmented and acne scars.

Authors:  Rory Boyd McGoldrick; Evgenia Theodorakopoulou; Ernest Anthony Azzopardi; Maxwell Murison
Journal:  Scars Burn Heal       Date:  2017-03-14

7.  Keloid treatment: what about adjuvant radiotherapy?

Authors:  Ilias G Petrou; Kheeldass Jugun; Eva Meia Rüegg; Thomas Zilli; Ali Modarressi; Brigitte Pittet-Cuénod
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-03

8.  Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway.

Authors:  Hui Ma; Xingwu Duan; Runtian Zhang; Hang Li; Yang Guo; Ye Tian; Min Huang; Guangshan Chen; Zi Wang; Lingling Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-15       Impact factor: 2.650

9.  Mast Cells in Skin Scarring: A Review of Animal and Human Research.

Authors:  Sara Ud-Din; Traci A Wilgus; Ardeshir Bayat
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.